share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Jun 22 07:01
Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc., executed a sale of 15,000 shares of common stock on June 18, 2024. The transactions were carried out in the open market with prices ranging from $132.22 to $136.92 per share, resulting in a total market value of approximately $2,003,561. After the sale, Afeyan directly holds 2,299,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering total 4,632,149 shares, with the largest portion held by Flagship Ventures Fund IV, L.P. The sale has been reported as completed.
Noubar Afeyan, associated with Moderna, Inc., executed a sale of 15,000 shares of common stock on June 18, 2024. The transactions were carried out in the open market with prices ranging from $132.22 to $136.92 per share, resulting in a total market value of approximately $2,003,561. After the sale, Afeyan directly holds 2,299,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering total 4,632,149 shares, with the largest portion held by Flagship Ventures Fund IV, L.P. The sale has been reported as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.